✦ LIBER ✦

Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

✍ Scribed by Katopodis, O.; Souglakos, J.; Stathopoulos, E.; Christopoulou, A.; Kontopodis, E.; Kotsakis, A.; Kalbakis, K.; Kentepozidis, N.; Polyzos, A.; Hatzidaki, D.; Georgoulias, V.

Book ID: 125344340
Publisher: Springer
Year: 2014
Tongue: English
Weight: 440 KB
Volume: 74
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2509-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy with gemcitabine, cisplatin

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

✍ Ioannis Boukovinas; Nikolaos Androulakis; Nikolaos Kentepozidis; Aris Polyzos; P 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 218 KB

Carboplatin plus gemcitabine as first-li

Carboplatin plus gemcitabine as first-line treatment in eldelry patients with non-small-cell lung cancer: Preliminary results of a multicenter phase ii trial by the Hellenic Oncology Researsch Group (HORG)

✍ Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Kentepozidis, N.; Polyzos, A.; Kotsa 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 48 KB

Docetaxel plus cisplatin and bevacizumab

Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group

✍ N. Kentepozidis, A. Kotsakis, A. Soultati… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 214 KB

Paclitaxel and bevacizumab as first-line

Paclitaxel and bevacizumab as first-line treatment in elderly women with HER-2 negative locally advanced or metastatic breast cancer: Preliminary results a multicenter phase II trial from Hellenic Oncology Research Group

✍ Vamvakas, L.; Karampeazis⁎, A.; Nikolaou, Ch.; Ardavanis, A.; Saloustros, E.; Ka 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 71 KB

The combination of gemcitabine and carbo

The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma : A Phase II study of the Hellenic Cooperative Oncology Group

✍ Aristotle Bamias; Lia A. Moulopoulos; Aggelos Koutras; Gerassimos Aravantinos; G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract ## BACKGROUND The toxicity of platinum‐based combinations represents a common problem for patients with advanced urothelial carcinoma. The authors previously reported encouraging efficacy for the combination of carboplatin and gemcitabine in patients considered to be unfit for cisplati

O12 FOLFOXIRI versus FOLFIRI as first li

O12 FOLFOXIRI versus FOLFIRI as first line treatment in metastatic colorectal cancer (MCC): a subgroup analysis for elderly patients of a multicenter randomized phase III trial from the Hellenic Oncology Research Group (HORG)

✍ Vamvakas, L.; Androulakis, N.; Syrigos, K.; Polyzos, A.; Ziras, N.; Athanasiadis 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB